ATE493679T2 - Augenoptische einrichtungen für aufrechterhaltene abgabe aktiver zusammensetzungen - Google Patents

Augenoptische einrichtungen für aufrechterhaltene abgabe aktiver zusammensetzungen Download PDF

Info

Publication number
ATE493679T2
ATE493679T2 AT06742806T AT06742806T ATE493679T2 AT E493679 T2 ATE493679 T2 AT E493679T2 AT 06742806 T AT06742806 T AT 06742806T AT 06742806 T AT06742806 T AT 06742806T AT E493679 T2 ATE493679 T2 AT E493679T2
Authority
AT
Austria
Prior art keywords
optical devices
eye optical
sustained delivery
active compositions
compositions
Prior art date
Application number
AT06742806T
Other languages
German (de)
English (en)
Inventor
Lynn Winterton
John Lally
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37027620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE493679(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE493679T2 publication Critical patent/ATE493679T2/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts or implants
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/00009Production of simple or compound lenses
    • B29D11/00038Production of contact lenses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/00865Applying coatings; tinting; colouring

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • Manufacturing & Machinery (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Eyeglasses (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
AT06742806T 2005-05-05 2006-05-04 Augenoptische einrichtungen für aufrechterhaltene abgabe aktiver zusammensetzungen ATE493679T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67796405P 2005-05-05 2005-05-05
US71987805P 2005-09-23 2005-09-23
PCT/EP2006/004193 WO2006117228A2 (en) 2005-05-05 2006-05-04 Ophthalmic devices for sustained delivery of active compounds

Publications (1)

Publication Number Publication Date
ATE493679T2 true ATE493679T2 (de) 2011-01-15

Family

ID=37027620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06742806T ATE493679T2 (de) 2005-05-05 2006-05-04 Augenoptische einrichtungen für aufrechterhaltene abgabe aktiver zusammensetzungen

Country Status (19)

Country Link
US (2) US9804295B2 (https=)
EP (1) EP1886169B2 (https=)
JP (1) JP5053261B2 (https=)
CN (1) CN101171531B (https=)
AR (1) AR055931A1 (https=)
AT (1) ATE493679T2 (https=)
AU (1) AU2006243345B2 (https=)
BR (1) BRPI0611434A2 (https=)
CA (1) CA2606073C (https=)
DE (1) DE602006019234D1 (https=)
DK (1) DK1886169T4 (https=)
ES (1) ES2357623T5 (https=)
MX (1) MX2007013739A (https=)
NO (1) NO340948B1 (https=)
PL (1) PL1886169T5 (https=)
PT (1) PT1886169E (https=)
TW (1) TWI375571B (https=)
WO (1) WO2006117228A2 (https=)
ZA (1) ZA200708953B (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5844508B2 (ja) 2005-11-25 2016-01-20 ノバルティス アーゲー メシル酸イマチニブのf結晶形
AR063561A1 (es) * 2006-11-06 2009-02-04 Novartis Ag Dispositivos oculares y metodos para fabricar y utilizar los mismos
US20080152540A1 (en) * 2006-12-22 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
US8689971B2 (en) * 2007-08-31 2014-04-08 Novartis Ag Contact lens packaging solutions
TWI551305B (zh) * 2007-08-31 2016-10-01 諾華公司 相對黏稠封裝溶液之用途
WO2009091733A2 (en) * 2008-01-14 2009-07-23 Coopervision International Holding Company, Lp Polymerizable contact lens formulations and contact lenses obtained therefrom
JP4869274B2 (ja) * 2008-03-21 2012-02-08 株式会社メニコン ソフトコンタクトレンズ包装製品及びソフトコンタクトレンズの包装方法
JP5721267B2 (ja) 2008-07-21 2015-05-20 ノバルティス アーゲー シリコーンハイドロゲルコンタクトレンズを製造する方法
US20100106128A1 (en) * 2008-10-23 2010-04-29 Shane Mao Contact lens cases for delivery of ophthalmic agents
TWI506333B (zh) * 2008-12-05 2015-11-01 Novartis Ag 用以傳遞疏水性舒適劑之眼用裝置及其製造方法
AU2012268828B2 (en) * 2008-12-05 2013-09-05 Alcon Inc. Ophthalmic devices for delivery of hydrophobic comfort agents
EP2370054B1 (en) * 2008-12-11 2015-10-07 Massachusetts Institute of Technology Contact lens drug delivery device
EP2399555B1 (en) * 2009-02-20 2016-12-07 Seed Co., Ltd. Sustainedly drug-releasing hydrogel contact lens, and drug releasing method using sustainedly drug-releasing hydrogel contact lens
AU2011233663B2 (en) * 2010-04-03 2016-04-14 Praful Doshi Medical devices including medicaments and methods of making and using same
CN103052496A (zh) 2010-07-30 2013-04-17 库柏维景国际控股公司 由水溶性乙烯醇共聚物形成的眼科装置模具、其中模制的眼科装置和相关方法
CN106896422B (zh) 2011-06-09 2021-03-23 爱尔康公司 具有纳米纹理化表面的硅氧烷水凝胶透镜
CA2859050C (en) 2011-12-21 2016-06-21 Novartis Ag Contact lenses containing carotenoid and method for making same
US9351827B2 (en) * 2012-04-03 2016-05-31 Johnson & Johnson Vision Care, Inc. Lens driver for variable-optic electronic ophthalmic lens
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
WO2016100457A1 (en) 2014-12-17 2016-06-23 Novartis Ag Reusable lens molds and methods of use thereof
CN107000344B (zh) 2014-12-17 2019-06-07 诺华股份有限公司 可再使用的镜片模具及其使用方法
JP6595120B2 (ja) 2015-12-03 2019-10-23 ノバルティス アーゲー コンタクトレンズパッケージング溶液
US10328645B2 (en) 2015-12-17 2019-06-25 Novartis Ag Reusable lens molds and methods of use thereof
US20180092776A1 (en) 2016-09-30 2018-04-05 Sara Heikali Method and device for treating and managing diseased ocular tissue
WO2019033119A1 (en) 2017-08-11 2019-02-14 Unity Biotechnology, Inc. TREATMENT OF OPHTHALMIC CONDITIONS SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS
WO2020166517A1 (ja) * 2019-02-12 2020-08-20 株式会社クラレ ポリマー組成物、ゲル、フィルムおよび粒子
MX2022002980A (es) 2019-09-16 2022-04-06 Amgen Inc Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos.
JP7419499B2 (ja) * 2019-09-18 2024-01-22 アルコン インク. 湿式充填のソフトヒドロゲル眼用インサート
HUE069794T2 (hu) 2019-11-04 2025-04-28 Alcon Inc Eljárás különbözõ puhaságú felületekkel rendelkezõ kontaktlencsék elõállítására
CN111116798B (zh) * 2019-12-24 2021-07-23 中国科学院广州能源研究所 一种改性的天然气水合物动力学抑制剂
WO2022023966A1 (en) 2020-07-28 2022-02-03 Alcon Inc. Contact lenses with softer lens surfaces
JP2025525733A (ja) 2022-08-17 2025-08-07 アルコン インク. ハイドロゲルコーティングをその上に有するコンタクトレンズ

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128305C (https=) 1963-09-11
FR2402525A1 (fr) 1977-09-12 1979-04-06 Toray Industries Procede de fabrication de compositions de lentilles de contact molles et nouveaux produits ainsi obtenus
JPS5590928A (en) * 1978-12-29 1980-07-10 Olympus Optical Co Ltd Endoscope objective lens which performs changing of magnification and focusing simultaneously
US4312575A (en) 1979-09-18 1982-01-26 Peyman Gholam A Soft corneal contact lens with tightly cross-linked polymer coating and method of making same
US4444711A (en) 1981-12-21 1984-04-24 Husky Injection Molding Systems Ltd. Method of operating a two-shot injection-molding machine
US4460534A (en) 1982-09-07 1984-07-17 International Business Machines Corporation Two-shot injection molding
US4625007A (en) 1982-09-30 1986-11-25 Polymer Technology Corporation Silicone-containing contact lens material and contact lenses made thereof
US5266563A (en) * 1984-06-11 1993-11-30 Biomatrix, Inc. Hyakyribate-poly (ethylene oxide) mixtures
US4713244A (en) 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
US4744980A (en) 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4810764A (en) 1988-02-09 1989-03-07 Bausch & Lomb Incorporated Polymeric materials with high oxygen permeability and low protein substantivity
US4910277A (en) 1988-02-09 1990-03-20 Bambury Ronald E Hydrophilic oxygen permeable polymers
US5177165A (en) 1990-11-27 1993-01-05 Bausch & Lomb Incorporated Surface-active macromonomers
EP0603268B1 (en) 1991-09-12 1996-12-18 BAUSCH & LOMB INCORPORATED Wettable silicone hydrogel compositions and methods
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
AU5092493A (en) 1992-09-08 1994-03-29 Allergan, Inc. Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
US6800225B1 (en) 1994-07-14 2004-10-05 Novartis Ag Process and device for the manufacture of mouldings and mouldings manufactured in accordance with that process
EP0637491B1 (de) 1993-07-29 1997-11-05 Novartis AG Verfahren und Vorrichtung zur Herstellung von Formkörpern
TW272976B (https=) 1993-08-06 1996-03-21 Ciba Geigy Ag
EP0655470B1 (de) 1993-11-26 1999-05-12 Novartis AG Vernetzbare Copolymere und Hydrogele
US5712356A (en) 1993-11-26 1998-01-27 Ciba Vision Corporation Cross-linkable copolymers and hydrogels
US5894002A (en) 1993-12-13 1999-04-13 Ciba Vision Corporation Process and apparatus for the manufacture of a contact lens
US5843346A (en) 1994-06-30 1998-12-01 Polymer Technology Corporation Method of cast molding contact lenses
US6407145B1 (en) 1994-08-04 2002-06-18 Novartis Ag Photocrosslinkable materials and applications
US5665840A (en) 1994-11-18 1997-09-09 Novartis Corporation Polymeric networks from water-soluble prepolymers
EP0712867B1 (de) 1994-11-18 1999-07-14 Novartis AG Polymere Netzwerke aus wasserlöslichen Präpolymeren
ATE178414T1 (de) 1995-02-03 1999-04-15 Novartis Ag Vernetzte polymere enthaltend ester- oder amidgruppen
AU698933B2 (en) 1995-02-03 1998-11-12 Novartis Ag Crosslinked polymers containing photoinitiators
TW349967B (en) 1995-02-03 1999-01-11 Novartis Ag Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor
AU4438696A (en) 1995-02-03 1996-08-21 Novartis Ag Crosslinked polymers
US5583463A (en) 1995-05-30 1996-12-10 Micron Technology, Inc. Redundant row fuse bank circuit
DE69625658T2 (de) * 1995-09-13 2003-07-17 Seikagaku Kogyo K.K.(Seikagaku Corp.), Tokio/Tokyo Kontaktlinse auf Basis photogehärteter Hyaluronsäure
JP2001502734A (ja) 1996-10-21 2001-02-27 ノバルティス アクチエンゲゼルシャフト 架橋性ポリマー
TW425403B (en) 1997-02-04 2001-03-11 Novartis Ag Branched polyurethane (meth)acrylate prepolymers, opthal-mic mouldings derived therefrom and processes for their manufacture
EP0867456A1 (de) 1997-02-04 1998-09-30 Novartis AG Ophthalmischer Formkörper
ATE216501T1 (de) 1997-02-21 2002-05-15 Novartis Erfind Verwalt Gmbh Opthalmische formmasse
GB9711818D0 (en) 1997-06-06 1997-08-06 Bausch & Lomb Contact lens packing solutions and methods for improving the comfort of disposable contact lenses
US6107365A (en) 1997-09-03 2000-08-22 The Regents Of The University Of California Biomimetic hydrogel materials
EP1017734B1 (en) 1997-09-16 2002-08-28 Novartis AG Crosslinkable polyurea polymers
TW429327B (en) 1997-10-21 2001-04-11 Novartis Ag Single mould alignment
US6943203B2 (en) 1998-03-02 2005-09-13 Johnson & Johnson Vision Care, Inc. Soft contact lenses
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US6367929B1 (en) 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US7052131B2 (en) 2001-09-10 2006-05-30 J&J Vision Care, Inc. Biomedical devices containing internal wetting agents
US6039913A (en) 1998-08-27 2000-03-21 Novartis Ag Process for the manufacture of an ophthalmic molding
EP1002807A1 (en) 1998-11-20 2000-05-24 Novartis AG Functionalized resin derived from polyallylamine
CA2682118A1 (en) 2000-03-24 2001-09-27 Novartis Ag Crosslinkable or polymerizable prepolymers
US6811805B2 (en) 2001-05-30 2004-11-02 Novatis Ag Method for applying a coating
JP2003033454A (ja) 2001-07-23 2003-02-04 Endo Mfg Co Ltd ゴルフクラブヘッドの製造方法
AR038269A1 (es) * 2002-01-09 2005-01-12 Novartis Ag Articulos polimericos que tienen un recubrimiento lubrico, y metodo para fabricarlos
AU2003258609A1 (en) 2002-08-14 2004-03-03 Novartis Ag Radiation-curable prepolymers
US7235195B2 (en) * 2002-09-06 2007-06-26 Novartis Ag Method for making opthalmic devices
US20040116564A1 (en) 2002-11-27 2004-06-17 Devlin Brian Gerrard Stabilization of poly(oxyalkylene) containing polymeric materials
US20040115270A1 (en) 2002-12-13 2004-06-17 Dharmendra Jani Absorption and controlled release of polyethers from hydrogel biomaterials
US7384590B2 (en) 2002-12-17 2008-06-10 Novartis Ag System and method for curing polymeric moldings
US7387759B2 (en) 2002-12-17 2008-06-17 Novartis Ag System and method for curing polymeric moldings having a masking collar
US20040119176A1 (en) 2002-12-23 2004-06-24 Bausch & Lomb Incorporated Method for manufacturing lenses
JP5047613B2 (ja) 2003-04-24 2012-10-10 クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ ヒドロゲルコンタクトレンズ及び包装システム及びそれらの製造方法
US7977430B2 (en) 2003-11-25 2011-07-12 Novartis Ag Crosslinkable polyurea prepolymers
US7786185B2 (en) 2004-03-05 2010-08-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising acyclic polyamides
US7249848B2 (en) 2004-09-30 2007-07-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents

Also Published As

Publication number Publication date
JP5053261B2 (ja) 2012-10-17
US20060251696A1 (en) 2006-11-09
PL1886169T3 (pl) 2011-05-31
AR055931A1 (es) 2007-09-12
NO20076252L (no) 2008-02-05
EP1886169B1 (en) 2010-12-29
DK1886169T3 (da) 2011-03-14
CN101171531B (zh) 2010-06-16
TW200716201A (en) 2007-05-01
WO2006117228A2 (en) 2006-11-09
TWI375571B (en) 2012-11-01
BRPI0611434A2 (pt) 2010-09-08
ES2357623T5 (es) 2016-03-29
US20170307780A1 (en) 2017-10-26
EP1886169A2 (en) 2008-02-13
WO2006117228A3 (en) 2007-02-01
CA2606073C (en) 2013-12-03
CA2606073A1 (en) 2006-11-09
AU2006243345A1 (en) 2006-11-09
AU2006243345B2 (en) 2010-03-18
CN101171531A (zh) 2008-04-30
PT1886169E (pt) 2011-03-07
JP2008539837A (ja) 2008-11-20
PL1886169T5 (pl) 2016-05-31
ZA200708953B (en) 2008-06-25
US9804295B2 (en) 2017-10-31
ES2357623T3 (es) 2011-04-28
DK1886169T4 (en) 2016-03-14
DE602006019234D1 (de) 2011-02-10
NO340948B1 (no) 2017-07-24
EP1886169B2 (en) 2015-12-09
MX2007013739A (es) 2008-01-21

Similar Documents

Publication Publication Date Title
ATE493679T2 (de) Augenoptische einrichtungen für aufrechterhaltene abgabe aktiver zusammensetzungen
DK1891911T3 (da) Linseisættelsessystem
DK1998783T3 (da) Oftalmiske sammensætninger omfattende povidoniod
BRPI0921789A2 (pt) Composto de benzotriazol, material para dispostivo oftálmico, lente intraocular e dispositivo oftálmico
DK1811959T4 (da) Oftalmiske sammensætninger
DK2054030T3 (da) Antimikrobielle midler
DK2086467T3 (da) Intraokularlinser
DK2092047T3 (da) Ophthalmiske præparater omfattende PEO-PBO-copolymerer
EP2212740A4 (en) EYOOPTIC LENS ELEMENT
BRPI0720216A2 (pt) Composições microbicidas
BRPI0716849A2 (pt) embalagens com abertura por descolamento
ITMI20062368A1 (it) Composizioni erbicide
BRPI0920137A2 (pt) implante ocular
ATE420611T1 (de) Akkomodatives intraokularlinsensystem
ATE482201T1 (de) Vr1-benzimidazolmodulatoren
EP3450425C0 (en) PERCARBOXYLIC ACID COMPOSITION
EP2069854A4 (en) EYOOPTIC LENS ELEMENT
EP2033596A4 (en) intraocular lens
DE602007013360D1 (de) Im wesentlichen glanzfreie intraokulare linsen
DK2185142T3 (da) Antiseptiske midler
FR2913196B1 (fr) Implant oculaire accomodatif
DK2041128T3 (da) Substituerede gamma-lactamer som terapeutiske agenser
DE602007011372D1 (de) Stenteinführungssystem
DE602005013617D1 (de) Polarisationsunempfindliche optische Faser
ITMI20080003A1 (it) Composizioni per uso oftalmico

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1886169

Country of ref document: EP